Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ELUXADOLINE vs ELVITEGRAVIR: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ELUXADOLINE vs ELVITEGRAVIR: Safety Overview

Metric ELUXADOLINE ELVITEGRAVIR
Total FAERS Reports 2,353 211
Deaths Reported 37 8
Death Rate 1.6% 3.8%
Hospitalizations 413 33
Average Patient Age 57.4 yrs 42.4 yrs
% Female Patients 77.7% 38.8%
FDA Approval Date Mar 14, 2025 Sep 24, 2014
Manufacturer Allergan, Inc. N/A
Route ORAL N/A
Marketing Status Prescription Discontinued